Anemocyte alongside Alliance for Regenerative Medicine (ARM)
We’re among the Alliance for Regenerative Medicine (ARM) leaders calling on the EU to act for the future of advanced therapies in Europe.
read moreWe’re among the Alliance for Regenerative Medicine (ARM) leaders calling on the EU to act for the future of advanced therapies in Europe.
read moreWe’re excited to announce our participation in the BIO International Convention 2025, taking place from June 16–19 at the Boston Convention & Exhibition Center.
read moreWe are thrilled to announce our participation in the 64th AFI Symposium, taking place from June 11 to 13, 2025, at the Palacongressi di Rimini.
read moreAnemocyte, a biotech company at the forefront of advanced therapy development, is excited to join the upcoming international conference on gene therapy in Gaithersburg, MD.
read moreAltheia Science proudly announces the success of its strategic collaboration with Anemocyte, a leading developer and manufacturer of pDNA and mRNA headquartered in Italy.
read moreGenenta and Anemocyte announce a collaboration for the manufacturing of starting materials for cutting-edge cell based therapies
read moreAnemocyte is excited to announce its participation as an attendee at TIDES USA 2025, taking place from May 19–22, 2025, at the Manchester Grand Hyatt in San Diego, California.
read moreAnemocyte announces its sponsorship and exhibition at the 28th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT), from May 13–17, 2025.
read moreAnemocyte is excited to announce its participation as an exhibitor at the International Society for Cell & Gene Therapy (ISCT) 2025 Annual Meeting, taking place from May 7 to 10 in New Orleans, Louisiana.
read moreThe “Anemocyte Run4Life” team—made up of five Anemocyte employees—took part in the 2025 Milano Marathon, choosing to support the Italian Cystic Fibrosis Research Foundation (FFC Ricerca – ETS)through the Rete del Dono fundraising platform.
read more